CrossrefInfokarte
Immune checkpoint inhibitor‑based vs. non‑immunotherapy subsequent treatment after progression on first‑line chemoimmunotherapy in extensive‑stage small cell lung cancer: A meta‑analysis
Oncology Letters · 2026-10-27 · 32 (6) · 1-13
DOI: 10.3892/ol.2026.15921 ↗Abstract
Kein Abstract verfügbar.
EUVIMED